-- CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:
We lift our target by $55 to $412, 41x our CY 27 EPS estimate of $10.06, above COHR's three-year average of approximately 20x as significant AI demand has improved growth and visibility well beyond historical levels. We lower our FY 26 (Jun.) EPS by $0.13 to $5.48, increase FY 27's by $0.74 to $8.32, and lift FY 28's by $2.31 to $11.91. COHR is, impressively, a full quarter ahead of schedule in hitting its initial goal of doubling indium phosphide (InP) production capacity in CY 26. The company is also ambitiously projecting another doubling of InP capacity in CY 27, which - as the main supply constraint for COHR's advanced AI products - offers significant upside to sales growth and margin expansion, in our view. We also like that COHR has inked additional long-term agreements for CPO-related products with major data center/systems customers following the NVDA agreement announced in March, which should continue to improve visibility and lead to smoother growth results, with orders now extending through CY 28.